Prophylaxis, preventive therapy, and targeted therapy are examples of therapeutic strategies. As first-line therapy, rituximab, immunosuppression reduction, and EBV-specific cytotoxic T-cell therapy are recommended, with unselected donor lymphocyte infusions or chemotherapy as second-line options; other methods, including antiviral drugs, are discouraged.